Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients

Muscle and Nerve

Volumn 33, Issue 1, 2006, Pages 138-141

  Chan, K Ming ^a   Strohschein, Fay J ^a   Rydz, David ^a   Allidina, Amyn ^a   Shuaib, Ashfaq ^a   Westbury, Chris F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Fatigue; Modafinil; Postpoliomyelitis syndrome; Randomized controlled trials

Indexed keywords

MODAFINIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TREATMENT FAILURE; EPWORTH SLEEPINESS SCALE; FATIGUE; FEMALE; HUMAN; MALE; PIPER FATIGUE SCALE; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESPONSE TIME; SCORING SYSTEM; SYMPTOM;

BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTPOLIOMYELITIS SYNDROME; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 30344463306     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20437     Document Type: Article

References (22)

1. Adler CH, Caviness JN, Hentz JG, Lind M, Tiede J. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 2003; 18:287-293.
2. Bodian D. Poliomyelitis: neuropathologic observations in relation to major symptoms. JAMA 1947;134:1148-1154.
3. Bodian D. Histopathologic basis of clinical findings in poliomyelitis. Am J Med 1949;6:563-578.
4. Broughton RJ, Fleming JA, George CF, Hill JD, Kryger MH, Moldofsky H, et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997;49:444-451.
5. Bruno RL, Cohen JM, Galski T, Frick NM. The neuroanatomy of post-polio fatigue. Arch Phys Med Rehabil 1994;75:498-504.
6. Bruno RL, Zimmerman JR, Creange SJ, Lewis T, Molzen T, Frick NM. Bromocriptine in the treatment of post-polio fatigue: a pilot study with implications for the pathophysiology of fatigue. Am J Phys Med Rehabil 1996;75:340-347.
7. Dalakas MC, Hallett M. The post-polio syndrome. In: Plum F, editor. Advances in contemporary neurology. Philadelphia: FA Davis; 1988. p 51-94.
8. Godefroy O, Cabaret M, Rousseaux M. Vigilance and effects of fatigability, practice and motivation on simple reaction time tests in patients with lesion of the frontal lobe. Neuropsychologia 1994;32:983-990.
9. Hassard TH. What sample size will I need? Understanding biostatistics. St. Louis: Mosby Year Book; 1991. p 167-182.
10. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-545.
11. MacDonald JR, Hill JD, Tarnopolsky MA. Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. Neurology 2002;59:1876-1880.
12. Mefferd RB Jr, Wieland BA, James WE. Repetitive psychometric measures: digit span. Psychol Rep 1966;18:3-10.
13. Parsons PE. Data on polio survivors from the National Health Interview Survey. Washington, DC: National Center for Health Statistics. 1989.
14. Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 1998;25: 677-684.
15. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002;72:179-183.
16. Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000;20:8620-8628.
17. Strohschein FJ, Kelly CG, Clarke AG, Westbury CF, Shuaib A, Chan KM. Applicability, validity, and reliability of the Piper Fatigue Scale in postpolio patients. Am J Phys Med Rehabil 2003;82:122-129.
18. Stuss DT, Stethem LL, Hugenholtz H, Picton T, Pivik J, Richard MT. Reaction time after head injury: fatigue, divided and focused attention, and consistency of performance. J Neurol Neurosurg Psychiatry 1989;52:742-748.
19. Talbot K, Stradling J, Crosby J, Hilton-Jones D. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy. Neuromuscul Disord 2003;13:357-364.
20. Trojan DA, Cashman NR. Post-poliomyelitis syndrome. Muscle Nerve 2005;31:6-19.
21. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology 2003;165:260-269.
22. U.S. Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998;43:88-97.